Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
MorningTradeLive features MeridianLink CEO Nicolaas Vlok discussing the company's first earnings report as a public company with Oliver Renick.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Nicolaas Vlok | CEO - MeridianLink, Inc.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
Machine Learning, Pulmonary Hypertension, and Echocardiography - Dr. Patricia Pellikka, a Cardiologist from Mayo Clinic
00:10:00
Raising Capital for Early Stage Startups|Marlon Nichols,Managing General Partner,MaC Venture Capital
00:10:00
Understanding 409A Valuations: Key Insights for Employee Stock Compensation | Mark Dempster, Co-Founder, Founders Circle Capital.
00:10:00
2023 Outlook for Australia's Oil and Gas: Insights with Managing Director Ian Lusted
00:10:00
Ben Smith on Fee-Only Financial Planning and Socially Responsible Investing | Ben Smith, Founder, Cove Financial Planning, LLC.
00:10:00
Zymeworks CEO Ali Tehrani on Biotech Success and Challenges | ALI TEHRANI, PH.D. , PRESIDENT & CHIEF EXECUTIVE OFFICER OF ZYMEWORKS INC
00:10:00
Jean-Claude Maurel of Medesis Pharma on Nanomicelle Technology's Promise in Alzheimer's Treatment | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Fullsix Unveils Diverse Pepper Solutions Across Retail, Banking, Hospitality, and Healthcare | Francesco Meani , CEO at Fullsix Spa
00:10:00
GoGold: Mexican Mining Company with Cash-Flowing Asset and Promising Los Rico's Project.
00:10:00
The Role of Qualifications and Ethics in Finance: Insights from Wol Kolade | Wol Kolade, Managing Partner, Livingbridge.
00:00:00
BOT Investor Webinar | 26 September 2023 - Vince Ippolito Executive Chairman, Botanix Pharmaceuticals Ltd
00:10:00
Richard Li’s PCCW To Sell Data Center Business To Digital|Mr Li was appointed an Executive Director and the Chairman of PCCW